YIV-906 potentiated anti-PD1 action against hepatocellular carcinoma by enhancing adaptive and innate immunity in the tumor microenvironment

Yang, XC; Lam, W; Jiang, ZL; Guan, FL; Han, X; Hu, R; Cai, W; Cheng, W; Liu, SH; Cheng, P; Cai, YP; Rattray, NJW; Johnson, CH; Chen, LP; Cheng, YC

Cheng, YC (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St,SHM B254, New Haven, CT 06510 USA.

SCIENTIFIC REPORTS, 2021; 11 (1):

Abstract

YIV-906 (PHY906) is a standardized botanical cancer drug candidate developed with a systems biology approach-inspired by a traditional Chinese herbal ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索